DGAP-News

Heidelberg Pharma AG: Annual General Meeting 2021 of Heidelberg Pharma Approves All Proposed Resolutions

DGAP-News: Heidelberg Pharma AG / Key word(s): AGM/EGM Heidelberg Pharma AG: Annual General Meeting 2021 of Heidelberg Pharma Approves All Proposed Resolutions 18.05.2021 / 14:57 The issuer is solely responsible for the content of this announcement. PRESS RELEASE

Annual General Meeting 2021 of Heidelberg Pharma Approves All Proposed Resolutions

Ladenburg, Germany, 18 May 2021 - Heidelberg Pharma AG (FSE: HPHA) today announced that the shareholders of the Company approved the resolutions of the administration with large majorities (ranged from 98,40% to 99,99%) during the virtual Annual General Meeting today.

- Resolution on the formal approval of the actions of the members of the Executive Management Board and the Supervisory Board for the fiscal year 2020

- Resolution on the appointment of the auditor of the annual financial statements and the consolidated financial statements for the 2020/2021 fiscal year

- Resolution to revoke the Conditional Capital II, as well as to amend the Articles of Association accordingly

- Resolution on one further amendment to the Articles of Association regarding a change in the law

- Resolution concerning the remuneration of the members of the Executive Management and Supervisory Board

Presence (including postal voting) at the Annual General Meeting 2021 corresponded to 81,57% of the current share capital.

Heidelberg Pharma made use of the option provided by the German legislature in view of the coronavirus pandemic to conduct ordinary annual general meetings also in 2021 without the physical presence of shareholders or their proxies. Via a password-protected web service, registered shareholders can, among other things, follow the entire Annual General Meeting live via video and audio, exercise their voting rights and submit questions.

Dr. Jan Schmidt-Brand, Chief Executive Officer and Chief Financial Officer of Heidelberg Pharma AG, commented: "Today, we successfully held our second Annual General Meeting in virtual format. We are pleased that the shareholders or their proxies took advantage of this opportunity and submitted their questions electronically. On behalf of the Management Board, I would like to thank the shareholders of Heidelberg Pharma AG for their confidence in our Company and their long-standing support."